Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue EBioMedicine Année : 2021

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

(1, 2) , (1, 2) , (3) , (4) , (1, 2) , (5) , (5) , (6) , (6) , (7) , (8) , (8) , (9, 10) , (9, 10) , (11) , (12) , (13) , (13) , (14) , (14) , (14) , (15) , (16) , (17) , (18) , (19) , (19) , (20) , (20) , (8) , (21) , (22) , (3) , (23) , (4) , (4, 24) , (25, 26) , (1, 2)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Jean Sibilia
  • Fonction : Auteur

Résumé

Background: Children are underrepresented in the COVID-19 pandemic and often experience milder disease than adolescents and adults. Reduced severity is possibly due to recent and more frequent seasonal human coronaviruses (HCoV) infections. We assessed the seroprevalence of SARS-CoV-2 and seasonal HCoV specific antibodies in a large cohort in north-eastern France. Methods: In this cross-sectional seroprevalence study, serum samples were collected from children and adults requiring hospital admission for non-COVID-19 between February and August 2020. Antibody responses to SARS-CoV-2 and seasonal HCoV (229E, HKU1, NL63, OC43) were assessed using a bead-based multiplex assay, Luciferase-Linked ImmunoSorbent Assay, and a pseudotype neutralisation assay. Findings: In 2,408 individuals, seroprevalence of SARS-CoV-2-specific antibodies was 7-8% with three different immunoassays. Antibody levels to seasonal HCoV increased substantially up to the age of 10. Antibody responses in SARS-CoV-2 seropositive individuals were lowest in adults 18-30 years. In SARS-CoV-2 seronegative individuals, we observed cross-reactivity between antibodies to the four HCoV and SARS-CoV-2 Spike. In contrast to other antibodies to SARS-CoV-2, specific antibodies to sub-unit 2 of Spike (52) in seronegative samples were highest in children. Upon infection with SARS-CoV-2, antibody levels to Spike of betacoronavirus OC43 increased across the whole age spectrum. No SARS-CoV-2 seropositive individuals with low levels of antibodies to seasonal HCoV were observed. Interpretation: Our findings underline significant cross-reactivity between antibodies to SARS-CoV-2 and seasonal HCoV, but provide no significant evidence for cross-protective immunity to SARS-CoV-2 infection due to a recent seasonal HCoV infection. In particular, across all age groups we did not observe SARS-CoV-2 infected individuals with low levels of antibodies to seasonal HCoV.
Fichier principal
Vignette du fichier
1-s2.0-S2352396421002887-main.pdf (3.13 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03591559 , version 1 (28-02-2022)

Licence

Paternité - CC BY 4.0

Identifiants

Citer

Tom Woudenberg, Stéphane Pelleau, Francois Anna, Mikael Attia, Francoise Donnadieu, et al.. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France. EBioMedicine, 2021, 70, pp.103495. ⟨10.1016/j.ebiom.2021.103495⟩. ⟨hal-03591559⟩
42 Consultations
44 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More